96 related articles for article (PubMed ID: 2569427)
1. Use of prostaglandin E2 vaginal suppositories in third-trimester fetal demise.
Martin RW; Helman NS; Martin JN; Morrison JC
Int J Gynaecol Obstet; 1989 Jul; 29(3):269-71. PubMed ID: 2569427
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
Kent DR; Goldstein AI; Linzey EM
J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 induction of abortion and fetal demise.
Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
[TBL] [Abstract][Full Text] [Related]
4. The use of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppositories for management of missed abortion and fetal death.
Fruzzetti F; Melis GB; De Cecco L; Genazzani AR; Fioretti P
Int J Gynaecol Obstet; 1991 Oct; 36(2):115-9. PubMed ID: 1683312
[TBL] [Abstract][Full Text] [Related]
5. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
Kirz DS; Haag MK
Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
[TBL] [Abstract][Full Text] [Related]
6. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
[TBL] [Abstract][Full Text] [Related]
7. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
[TBL] [Abstract][Full Text] [Related]
8. Trial of 16,16 dimethyl trans delta 2 prostaglandin E1 methyl ester vaginal pessaries for management of second trimester fetal death.
Goh TH
Aust N Z J Obstet Gynaecol; 1984 Nov; 24(4):294. PubMed ID: 6598382
[No Abstract] [Full Text] [Related]
9. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
Gruber WS; Baumgarten K
Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
[TBL] [Abstract][Full Text] [Related]
10. Gemeprost vaginal pessaries for inducing third-trimester intrauterine deaths.
Shafi MI; Constantine G; Byrne P; Luesley DM; Pogmore JR
Br J Obstet Gynaecol; 1989 Jun; 96(6):745-6. PubMed ID: 2804000
[TBL] [Abstract][Full Text] [Related]
11. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
Scher J; Jeng DY; Moshirpur J; Kerenyi TD
Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
[TBL] [Abstract][Full Text] [Related]
12. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
Owen J; Hauth JC
Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
[TBL] [Abstract][Full Text] [Related]
13. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
[TBL] [Abstract][Full Text] [Related]
14. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
Boehm FH; Killam AP; Chambers JF; Davidson KK
Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
[TBL] [Abstract][Full Text] [Related]
16. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
[TBL] [Abstract][Full Text] [Related]
17. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
Smith SK; Baird DT
Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
[TBL] [Abstract][Full Text] [Related]
18. Termination of third-trimester pregnancy before term with gemeprost vaginal pessaries.
Frambach T; Müller T; Blissing S; Sütterlin M; Dietl J
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):523-6. PubMed ID: 12047305
[TBL] [Abstract][Full Text] [Related]
19. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
[TBL] [Abstract][Full Text] [Related]
20. [Combined pericervical and intramuscular administration of prostaglandin for the termination of pregnancy in the 2d and 3d trimester].
Grünberger W; Husslein P
Geburtshilfe Frauenheilkd; 1983 Apr; 43(4):240-4. PubMed ID: 6553545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
